Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onalespib (AT13387) +/- Imatinib in Advanced GIST
NCT01294202Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Mar 2011
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of onalespib in gastrointestinal stromal tumor (GIST), sponsored by Astex Pharmaceuticals. Started Mar 2011; status: completed.
02
Drugs
onalespib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01294202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01294202.